Australian Infrastructure Stock News

Recently, UBS upgraded Treasury Wine Estates to Neutral from Sell while cutting its earnings outlook, as the company cancelled its dividend and announced a near A$1.00 billion pre-tax write-down on its US winemaking and premium brand assets following a A$1.30 billion California vineyard acquisition. This combination of higher debt, halted shareholder payouts and substantial asset impairments has sharpened market attention on Treasury Wine Estates’ balance sheet resilience and business mix...

4DMedical Limited recently completed an A$83,000,002 follow-on equity offering at A$5.90 per share, shortly after announcing that its CT:VQ imaging technology had received CE Mark certification for commercial use across the European Union. The CE Mark for CT:VQ gives 4DMedical access to one of the world’s largest respiratory imaging markets, leveraging existing CT infrastructure without needing radiotracers or specialised nuclear medicine facilities. We’ll now examine how EU commercial...

Perenti has completed further on-market share buy-backs as part of its capital management program and, in April 2026, confirmed the appointment of Dr Vanessa Torres as its new CEO and Managing Director, following a planned transition from Mark Norwell. This leadership change brings more than 25 years of resources-sector experience into the role at a time when Perenti reports record revenue, a cleaner balance sheet and a high proportion of forward revenue secured under existing...

We wouldn't blame Fenix Resources Limited ( ASX:FEX ) shareholders if they were a little worried about the fact that...

Some Challenger Limited ( ASX:CGF ) shareholders may be a little concerned to see that the MD, CEO & Director, Nicolas...

AI in healthcare sits at the crossroads of two powerful forces: the push for better diagnostics and treatment, and a world where inflation, energy shocks, and policy uncertainty keep pressure on costs and access. While central banks, bond markets, and geopolitics keep volatility elevated, AI tools that improve accuracy, reduce waste, and speed up research can look attractive to investors seeking structural growth themes rather than short term macro calls. This article highlights three stocks...

Focus Minerals Limited's ( ASX:FML ) strong earnings report was rewarded with a positive stock price move. We did some...

Some Gold Hydrogen Limited ( ASX:GHY ) shareholders may be a little concerned to see that insider John Titus recently...

As the Australian market looks to rebound with a projected 0.2% rise after the Easter long weekend, investors are keeping an eye on global developments such as potential U.S.-Iran ceasefire talks and their impact on market sentiment. In this context, penny stocks—though an older term—remain relevant for those interested in smaller or newer companies that may offer both affordability and growth potential. By focusing on stocks with strong financial foundations, investors can uncover...

Potential Bhagwan Marine Limited ( ASX:BWN ) shareholders may wish to note that the Non-Executive Chairman, Anthony...

Insiders who purchased US$3.09m worth of Genmin Limited ( ASX:GEN ) shares over the past year recouped some of their...

Just because a business does not make any money, does not mean that the stock will go down. Indeed, Centaurus Metals...

Recent share performance and context Life360 (ASX:360) has been under pressure, with the share price down about 6% over the past day, 3% over the past week, and 14% over the past month. Across the past 3 months, the stock shows a 42% decline, while year to date it is down roughly 42%. Over the past year, however, total return sits modestly positive at about 4%. For longer term holders, the picture looks different. Total return over 3 years is around 3x and over 5 years roughly 2.8x, figures...

With Australian shares poised for a modest advance, driven by optimism surrounding geopolitical tensions in the Middle East, investors are keenly observing how these developments might influence market dynamics. In such an environment, dividend stocks often attract attention for their potential to provide steady income streams amidst fluctuating market conditions.

As Australian shares edge towards a 0.5% advance, buoyed by optimism surrounding geopolitical developments in the Middle East, investors are keenly watching how these shifts might influence market dynamics across various sectors. In this evolving landscape, growth companies with high insider ownership often attract attention, as insiders' stakes can signal confidence in the company's potential and alignment with shareholder interests.

As Australian shares advance amid hopes of easing geopolitical tensions, the market is witnessing a cautious optimism that has led to a modest rise in indices. In this environment, identifying stocks trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

As Australian shares advance, buoyed by optimism surrounding geopolitical developments and economic normalization, the market is witnessing a renewed interest in small-cap stocks that could benefit from these shifting dynamics. In this environment, identifying promising small-cap companies with strong fundamentals and growth potential can be key to uncovering hidden opportunities within the Australian market.

As Australian shares edge towards a 0.5% advance, buoyed by optimism surrounding geopolitical developments, investors are keenly observing how these shifts might impact various market segments. Penny stocks, despite their somewhat antiquated name, continue to intrigue those seeking opportunities in smaller or emerging companies. With a focus on financial robustness and potential for growth, this article explores three penny stocks that stand out for their promising attributes in the current...

Dateline Resources Limited has completed a A$50 million follow-on equity offering at A$0.40 per share, including attached options and a subsequent direct listing, to support development of its Colosseum Gold-REE Project and broader critical minerals portfolio. This capital raise, which lifts the company’s cash position to about A$96 million, underscores its focus on advancing the Colosseum bankable feasibility study and accelerating site development works. We’ll now examine how this...

Ramsay Health Care recently reported a stronger than expected first-half fiscal 2026 result, announced the divestment of its 52.79% stake in European provider Ramsay Santé to refocus on Australian hospitals, increased its interim dividend, and confirmed the consolidation of support teams at a new North Shore Health Precinct head office. Together, these moves point to a clearer concentration on its core Australian hospital operations, a reshaped geographic footprint, and a recalibrated...

WHSP Holdings (ASX:SOL) has drawn fresh attention after reporting half year sales of A$620 million and net income of A$2,303 million, along with a higher interim dividend of A$0.48 per share. See our latest analysis for WHSP Holdings. The recent half year result and higher interim dividend have arrived alongside firm share price momentum, with a 10.6% year to date share price return and a 23.4% total shareholder return over the past year signalling strengthening interest from investors. If...

Vulcan Energy Resources (ASX:VUL) has appointed HOCHTIEF Chief Strategy Officer Roberto Gallardo as a non executive director, coinciding with construction progress and existing offtake agreements for its Lionheart lithium and renewable energy project in Europe. See our latest analysis for Vulcan Energy Resources. Despite the board refresh and progress at the Lionheart project, Vulcan Energy Resources’ recent 90 day share price return of 32.92% and year to date share price return of 25.45%...

Australian shares are poised for a modest advance as investors anticipate positive developments in the Middle East that could stabilize various markets. Amidst these shifting conditions, penny stocks—once a buzzword but now more of a niche—remain an intriguing area for potential growth, especially when they are supported by strong financial health. This article will explore three such penny stocks on the ASX that offer compelling opportunities with less risk than one might expect, showcasing...

Telix Pharmaceuticals recently announced that David Gill will join its Board as a Non-Executive Director on 11 May 2026, with plans for him to succeed Dr. Mark Nelson as Chair while Nelson remains a Non-Executive Director. The appointment brings a veteran life sciences executive with extensive radiopharmaceutical, capital markets and governance experience onto Telix’s Board, potentially reshaping how the company balances growth ambitions with oversight as a dual-listed business. We’ll now...